Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2023 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Interrater Agreement and Reliability of PERCIST and Visual Assessment When Using 18F-FDG-PET/CT for Response Monitoring of Metastatic Breast Cancer.
Diagnostics (Basel). 2020 Nov 24;10(12):1001. doi: 10.3390/diagnostics10121001.
Diagnostics (Basel). 2020.
PMID: 33255442
Free PMC article.
Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer.
Naghavi-Behzad M, Oltmann HR, Alamdari TA, Bülow JL, Ljungstrøm L, Braad PE, Asmussen JT, Vogsen M, Kodahl AR, Gerke O, Hildebrandt MG.
Naghavi-Behzad M, et al. Among authors: ljungstrom l.
Cancers (Basel). 2021 Aug 13;13(16):4080. doi: 10.3390/cancers13164080.
Cancers (Basel). 2021.
PMID: 34439232
Free PMC article.
Item in Clipboard
FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST.
Vogsen M, Bülow JL, Ljungstrøm L, Oltmann HR, Alamdari TA, Naghavi-Behzad M, Braad PE, Gerke O, Hildebrandt MG.
Vogsen M, et al. Among authors: ljungstrom l.
Diagnostics (Basel). 2021 Apr 19;11(4):723. doi: 10.3390/diagnostics11040723.
Diagnostics (Basel). 2021.
PMID: 33921580
Free PMC article.
Item in Clipboard
Cite
Cite